Stay updated on Exemestane in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Exemestane in NSCLC Clinical Trial page.

Latest updates to the Exemestane in NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check37 days agoChange DetectedThe page has undergone significant content removal, particularly regarding a phase II therapeutic study for advanced non-small cell lung cancer, including detailed inclusion and exclusion criteria. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference29%
- Check45 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check88 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check102 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check110 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Exemestane in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Exemestane in NSCLC Clinical Trial page.